XML 38 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities            
Net income (loss) $ 140,999 $ (433,781) $ 124,432 [1] $ (481,735) [1]    
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:            
Depreciation and amortization [1]     18,798 22,936    
Provision for losses on accounts receivable [1]     1,614 1,176    
Share-based compensation [1]     8,606 14,865    
Fair value and remeasurement adjustments, non-cash (includes $3,011 and $196,743 from related parties for 2025 and 2024, respectively) [1]     (6,789) 189,507    
Non-cash interest and other (includes $(268) and $(5,916) from related parties for 2025 and 2024, respectively) [1]     6,584 (3,325)    
Depreciation of rental merchandise [1]     6,698 8,221    
Net foreign currency (gains) losses [1]     (481) 347    
Income from equity investments (25,603) (10) (25,051) [1] (6) [1]    
Dividends from equity investments [1]     122 74    
Deferred income taxes [1]     9,100 1,445    
Impairment of goodwill and tradenames [1]     1,500 27,681    
Gain on disposal of discontinued operations [1]     (66,795) 0    
(Gain) loss on sale or disposal of fixed assets and other [1]     (1,147) 87    
Gain on sale and deconsolidation of businesses (5,372) 0 (86,213) [1] (314) [1]    
(Loss) gain on extinguishment of debt 10,266 (120) 20,693 [1] (120) [1]    
Gain on senior note exchange [1]     (54,986) 0    
Income allocated and fair value adjustment for mandatorily redeemable noncontrolling interests [1]     0 785    
Change in operating assets and liabilities:            
Amounts due to/from clearing brokers [1]     (14,668) 10,423    
Securities and other investments owned [1]     39,126 478,436    
Securities borrowed [1]     (29,298) 2,127,999    
Accounts receivable [1]     3,542 (759)    
Prepaid expenses and other assets (includes $3,373 and $(12,777) from related parties for 2025 and 2024, respectively) [1]     6,728 3,789    
Accounts payable, accrued expenses and other liabilities [1]     (13,665) (16,940)    
Amounts due to/from related parties and partners [1]     (2,290) (2,161)    
Securities sold not yet purchased [1]     6,672 (3,836)    
Deferred revenue [1]     (4,609) (5,982)    
Securities loaned [1]     26,402 (2,125,754)    
Net cash (used in) provided by operating activities [1]     (25,375) 246,839    
Cash flows from investing activities            
Purchases of loans receivable (includes $(50,853) and $(14,359) from related parties for 2025 and 2024, respectively) [1]     (66,650) (63,203)    
Repayments of loans receivable (includes $50,883 and $30,553 from related parties for 2025 and 2024, respectively) [1]     105,378 72,373    
Proceeds from sales of loans receivable (includes $6,611 and $— from related parties for 2025 and 2024, respectively) [1]     10,415 22,785    
Proceeds from loan participations sold [1]     4,475 0    
Acquisition of businesses and minority interest, net of $— and $604 cash acquired for 2025 and 2024, respectively [1]     0 (19,142)    
Proceeds from sale of business, net of cash sold and other [1]     94,938 (135)    
Purchases of property, equipment and intangible assets [1]     (9,148) (5,441)    
Proceeds from sale of property, equipment, intangible assets, and other [1]     7,173 0    
Distributions from equity investment [1]     34,869 0    
Purchases of equity and other investments [1]     (6,621) (533)    
Consolidation of VIE [1]     359 0    
Proceeds from sale of discontinued operations, net of cash sold [1]     114,032 0    
Net cash provided by investing activities [1]     289,220 6,704    
Cash flows from financing activities            
Proceeds from revolving line of credit [1]     46,374 40,311    
Repayment of revolving line of credit [1]     (50,627) (64,304)    
Proceeds from note payable [1]     850 15,000    
Repayment of notes payable and other [1]     (13,138) (5,690)    
Repayment of term loan [1]     (310,253) (45,606)    
Proceeds from term loan [1]     235,550 0    
Redemption of senior notes [1]     (145,302) (140,491)    
Payment of debt issuance and offering costs [1]     (11,253) (984)    
Payment of contingent consideration [1]     (1,376) (1,406)    
Payment of employment taxes on vesting of restricted stock [1]     0 (3,136)    
Common dividends paid [1]     0 (33,627)    
Preferred dividends paid [1]     0 (4,030)    
Distribution to noncontrolling interests [1]     (3,249) (3,173)    
Contributions from noncontrolling interests [1]     0 2,957    
Proceeds from exercise of warrants [1]     0 653    
Net cash used in financing activities [1]     (252,424) (243,526)    
Increase in cash, cash equivalents and restricted cash [1]     11,421 10,017    
Effect of foreign currency on cash, cash equivalents and restricted cash [1]     546 (5,233)    
Net increase in cash, cash equivalents and restricted cash [1]     11,967 4,784    
Cash, cash equivalents and restricted cash from continuing operations, beginning of period [1]     248,651 218,546 $ 218,546  
Cash, cash equivalents and restricted cash from discontinued operations, beginning of period [1]     8,025 15,293 15,293  
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total [1] 268,643 238,623 268,643 238,623 256,676 $ 233,839
Cash, cash equivalents and restricted cash from continuing operations, end of period [1] 268,643 227,108 268,643 227,108 248,651  
Cash, cash equivalents and restricted cash from discontinued operations, end of period [1] $ 0 $ 11,515 0 11,515 $ 8,025  
Supplemental disclosures:            
Interest paid     55,011 152,730    
Taxes paid     $ 2,139 $ 3,807    
[1] Amounts presented contain results from both continuing and discontinued operations. Refer to Note 4 – Discontinued Operations and Assets Held for Sale for additional information regarding cash flow associated with the results of discontinued operations.